1 Participants carrying one copy of the variant lost an average of 1.7 pounds more over a median of eight months of treatment compared to non-carriers, while those carrying two copies lost approximately 3.3 pounds more
Hair loss caused by telogen effluvium is temporary
Currently, there is only two classes of drugs approved for the treatment of AD: N-methyl D -aspartate (NMDA) antagonist (memantine), and cholinesterase inhibitors (tacrine, Donepezil, galantamine, rivastigmine)
GLP-1s are years ahead of any other potential breakthrough therapies for addiction treatment in the pipeline (with the partial exception of the new Vertex non-addictive painkiller, suzetrigine)
Is there a real relationship between the presence of helicobacter pylori in dental plaque and gastric infection
After 12 weeks treatment, the reductions in HbA1c from baseline were 0.96% with 1.8mg MAR709, 0.9% with 1mg tirzepatide and 1.7% with 5mg tirzepatide